This study uses paired single-nucleus chromatin accessibility and gene expression profiling across Alzheimer’s disease, Pick’s disease and progressive supranuclear palsy to map disease-dynamic cis-regulatory elements (CREs). Dynamic chromatin changes concentrate genetic risk in glial cell states and co-regulated regulatory modules. Integrating GWAS, sn-eQTLs and MPRA validates functional noncoding variants that tune lysosomal, lipid and vesicular pathways. Experimental CRISPRa and histology support a stress-inducible SOX10-driven glial program linked to resilience.
0:00Welcome to Base by Base, the papercast that brings genomics to you wherever you are. Thanks for listening, and don't forget to follow and rate us in your podcast app. You know, when we think about neurodegenerative diseases, our minds just, well, it automatically goes straight to the neurons.
0:14Right. It's always about the neurons. Yeah, we just picture this linear, tragic narrative that is strictly about dying brain cells. But what happens to your brain when it supports staff, the selves that are actually supposed to clean up the mess and keep things running, starts misreading the genetic instruction manual.
0:31It completely changes the picture. Exactly. We are learning that the secret to brain resilience might actually lie in these dynamic genetic switches flipping inside glial cells. And those act as the brain's caretakers.
0:44Right, the unsung heroes, really. Yeah. So how could understanding these hidden non-coding genetic switches completely change the way we treat dementias? And, you know, what really happens when a brain cell borrows a survival tool from an entirely different cell type just to stay alive?
1:01To answer that question, we really have to look at a monumental new study. Today we celebrate the work of Shiahan, Jessica Rexak, and the extensive research teams at UCLA, Yale, Mount Sinai, and UCSF, who have advanced our understanding of the epigenomic drivers of neurodegenerative diseases.
1:19Yeah, and we really should emphasize the sheer scale of what they've accomplished here to uncover these hidden survival tools. I mean, the numbers are wild. Oh, absolutely. They profiled over 600,000 individual nuclei to map the human brain's epigenomic landscape.
1:37It's just an absolutely massive undertaking, really designed to decode the hidden architecture of these conditions. 600,000 individual nuclei. That is like trying to map the behavior of every single resident in a major city, you know, one by one during a massive crisis.
1:51That's a great way to put it. And the crisis we are looking at in this deep dive involves twopathies. Right. And for those who might be catching up or just new to the field, toopathies are this group of diseases characterized by an abnormal accumulation of towel protein tangles inside the brain.
2:07Exactly. And Alzheimer's disease usually gets well, the lion's share of the attention there. It does, but primary towopathies, like picks disease, which we'll just call Pidey today, and progressive supernuclear palsy, or PSP, those are equally devastating.
2:24Duly devastating. And what is so fascinating, and frankly, baffling, is that they look clinically and genetically very different from each other, even though, you know, this toxic towel protein is the common enemy.
2:35Exactly. That stark clinical difference is the core scientific problem the study addresses. I mean, think about it. Pix disease often presents as a form of frontotemporal dementia. It drastically affects a person's behavior, their personality, language.
2:49Right, very cognitive in behavioral. But PSP on the other hand, heavily impacts movement, balance, and eye coordination. So why do different topathies destroy entirely different parts of the brain and why do they present so differently in patients?
3:01Which is the big mystery. Right. We have known for a long time that neurons are the cells that are selectively vulnerable to dying. But glyle cells, so that includes your astrocytes, your microglia, and your oligodendrocytes, they are increasingly recognized as the key players here.
3:20The frontline responders. Exactly. They are actively managing the brain's reaction to stress. So the goal of this deep dive is to really explore how our underlying genetic risk factors specifically rewire these glial cells when that Tao pathology invades the brain.
3:36To really understand this rewiring. I like to think of the brain's genetics as like a massive theater production. Okay I like that. So the genes themselves, the actual sequences that make the proteins.
3:46those are the actors. But the non-coding genetics variants, the vast stretches of DNA that control, you know, when and where and how loudly a genus expressed. Those are the directors. Right, the ones pulling the strings.
3:57Exactly. And we've known for a while that these non-coding variants actually hold the vast majority of disease risk. It was rarely a mutated actor. It's usually a bad director. But figuring out exactly which director is talking to which actor, in which specific cell during a disease.
4:13That has been just a massive mystery. It has been the major bottleneck of the entire field, honestly. So to solve it, the researchers used an incredibly powerful combination of methodologies. They used single nucleus atax sec, paired with single nucleus RNA sequencing.
4:28On human brains, right? Yes, on 41 postmortem human brains. They directly compared healthy controls against Alzheimer's, Pix disease, and PSP cases. And crucially, they didn't just blend up the whole brain into a smoothie.
4:42Right, because location matters. Exactly. They looked at highly specific regions with different vulnerabilities to match those clinical symptoms we talked about. They focused on the pre-central gyrus, which is highly affected in PSP and regulates movement.
4:55And the insula, which is highly affected in picks disease and is involved in emotion and social behavior. I thought I read they looked at a 3rd region too, right? They did. They initially looked at the Calcane cortex, which is a visual processing region with low pathology across the board.
5:10But they actually ended up excluding it from the main comparative analysis. Oh why is that? There was just extreme biological variability in the cellular makeup of those specific samples. It skewed the data too much.
5:22Okay, let's unpack this a bit, specifically the single nucleus atex sec part. For someone who understands, you know, basic DNA sequencing, reading the letters, but maybe he hasn't spent time in an epigenetics lab.
5:34How does ATEC actually work to find these directors in this context? Well, it helps to think of the genome inside a cell's nucleus as a massive sprawling library. Every single cell in your body contains the exact same library of books.
5:50But, um, an astracite doesn't need to read the same books as a neuron to do its job. Right, it only needs its own specific manuals. Exactly. So the cell tightly packs away the books it doesn't need into a lock vault.
6:01That is your closed chromentin. Those are the inactive regions. But the books it does need, those are left wide open on the reading desks. That is open chromatin. So Atex Sec is a specialized molecular tool that basically tags only the open books.
6:16Oh, wow. Yeah, it lets us see exactly which regulatory elements, you know, which directors are sitting open on the desks of specific cells at specific times. And then they pair that with RNA sequencing.
6:28Right. RNA sequencing measures the actual messages the cell is producing. So by putting them together, we can see not only which books are open, but which pages are actively being read. So it is giving us a real-time map of the command center.
6:40That's incredible. But, you know, identifying an open book doesn't necessarily prove that the instructions on the page are actually causing a disease. The critique in this field is always about, well, correlation versus causation.
6:52Right, just because a switch is flip doesn't mean it's causing the fire. Exactly. So how do the researchers bridge that gap? They took an incredibly innovative step to prove these genetic switches actually work in living cells.
7:04They utilized massively parallel reporter assays or MPRAs. Human microglial cell lines, right? Yes. Okay, an NPRA. So if ATAXEC is finding the open script in the library, how does the reporter assay fit into our theater analogy?
7:19If AtaxSec finds the open script, an NPRA is essentially taking a photocopy of those specific pages, handing them to a test actor, a reporter gene, and seeing if they actually recite the lines and light up the stage.
7:30Okay, literally light up. Literally. In the lab, researchers take 1000s of the specific non-coding DNA sequences they suspect are acting as switches, and they attach them to a recorder gene, like a fluorescent protein, inside a living cell.
7:45So if it works, it glows. Exactly. If the DNA sequence is truly an active regulatory switch, it will turn on the reporter and the cell will literally glow. That is a brilliant way to establish causation.
7:56You find the light switch, and then you wire it to a test bulb to prove it actually conducts electricity. Right. By doing this in human microglia, they experimentally validated 1000s of the genetic variants they found.
8:08They prove that these regions truly function as active regulatory switches in the immune cells of the brain, rather than just being, you know, statistical correlations sitting in a database. And what they found when they look to these validated switches.
8:22completely shifts how we need to think about genetic risk. It really does. The traditional, perhaps overly simplistic assumption is that genetic risk is baked permanently into a cell's basic identity. You are born with it and it is always there.
8:36Like a structural flaw. Right. But this study revealed that disease heritability isn't just found in static cell states. Instead, the genetic risk for these towopathies is heavily concentrated in the highly dynamic regions of chromatin.
8:50Dynamic meaning they change. Yes, these are the regulatory switches that specifically flip open or closed only in response to the disease context. The heritability, the real danger is hiding in the cell's reaction to the disease, not just its everyday resting state.
9:04That is a massive paradigm shift. So the risk isn't just, you know, you were born with a defective astracite. The risk is when your astracite encounters toxic tau tangles 40 years from now, its specific emergency reaction plan is going to be flawed.
9:19Exactly. And that leads to a fascinating divergence they found between the dying neurons and the surviving glialia. Right, because they behave completely differently. Precisely. When we look at the neurons, the cells that are actually degenerating, they show a fairly conserved generic stress response, whether it is Alzheimer's, picks, or PSP, dyeing neurons largely pack up their books and shut down in the exact same way.
9:43But the glelia. They are the active reactors, they display incredibly diverse disorder specific reactions. Astrosytes in particular show the most profound differences in epigenomic dysregulation across the 3 diseases.
9:57Which beautifully explains why these diseases look so different in the clinic, despite all being driven by the exact same toxic towel protein. The grill cells, the support staff are reacting completely differently based on the specific disease environment.
10:10And we see a critical, almost chilling pattern when we track the disease severity across the brain. What kind of pattern? As you move from a moderately affected brain region, like the pre-central gyrus in picks disease, to a highly affected one, like the insula, there is a highly coordinated stepwise transition of gene deactivation.
10:30So they just start turning things off. Yes, the chromatin literally closes up across the board. The books are being packed back into the vault in a very deliberate sequence. This leads to the loss of synaptic regulation in the neurons, and crucially, the loss of survival and immune functions in the glia.
10:48It's like watching the power grid of a city fail. Yeah. You know, 1st the street lights go out, then whole neighborhoods go dark as the storm gets worse. That's exactly what it looks like But here is where it gets really interesting.
10:58Amidst all this cellular shutdown and rolling blackouts, they found 2 incredibly specific standout glial cell states that seem to be putting up a highly specialized fight against the pathology. Let's talk about the 1st one.
11:13The microglial state they named MGC 4. Right, MGC 4. So this is a highly specialized microglial state strongly associated with picks disease. Okay. Remember, Pix disease is a specific type of fronto temporal dementia or FTD.
11:27When the researchers cross referenced their epigenomic map with genome wide association data for FTD, they found that this specific microglial state, MGC4 captures a massive amount of the genetic heritability for the disease.
11:41So the genetic risk for getting phonotemple dementia isn't spread evenly. It is funneling directly through this very specific type of microglia. What exactly is the MGC4 command center doing differently than a normal microbilial cell?
11:54Well, it is heavily driven by 2 main directors? Transcription factors known as MEF2C and SPI one? Okay what do they do? What these directors are commanding the cell to do is to massively activate its lysosomal function and its fingle lipid clearance.
12:09Wait, Spingalipids? We need to break that down. Why is a brain cell suddenly obsessed with clearing lipids? The finger lipins are complex, fatty molecules that are a major component of myelin. The insulation on the nerves.
12:19Exactly. Milan is the protective fatty insulation wrapped around the long cables of your neurons, allowing signals to travel quickly. In pick's disease, as the brain tissue gets heavily damaged, those neuronal cables break down, leaving behind a massive amount of myelin debris.
12:37So it's basically hazardous fatty waste. Exactly. It's highly toxic. MJC4 is specifically wired to deal with this severe metabolic stress by eating and safely clearing out that lipid rich debris before it causes further toxicity.
12:50It is essentially transforming into a highly specialized hazmat crew, specifically designed for toxic fat spills. That is credible. really is an amazing survival strategy. And then we have the 2nd standout cell state, which is an astrosite state they called a pornus.c one.
13:05and this one is enriched specifically in PSP. Yes. And a point of start, C1 behaves very differently from the cells around it in the PSP brain. While the surrounding cells are experiencing that rolling blackout, losing chromit and accessibility and packing their books away, Boisead C1 preserves its epigenomic stability.
13:21It just refuses to shut down. It stubbornly refuses. In fact, it actively gains open chromatin, and it does so specifically at the genetic locations associated with PSP risk. So while everything else is failing, a priest DNC one is kicking down the library doors and opening new books.
13:38What instructions is it aggressively reading? It is uniquely driven to upregulate something called snare dependent vesical trafficking. It's activating specific genes like YKT6 and SDX6. Okay, why does physical trafficking matter so much here?
13:52Well, to understand why this matters, you have to picture what Tao pathology does to the inside of a cell. It creates massive physical roadblocks, but the cell still needs to move nutrients in and ship garbage out.
14:04Right. It does this using vesicles, which are essentially tiny cellular delivery trucks. Snare proteins are the molecular docking mechanisms, the loading bay doors, that allow these trucks to fuse with membranes and drop off their cargo.
14:17Ah, so if the cell is completely choked with toxic roadblocks, Asic.c1 survives by drastically scaling up its logistics network. It is building more delivery trucks, and more loading bays to force the cellular postal service to keep running despite the traffic jam.
14:32Precisely. It's heavily optimizing its vesicle transport to clear out the toxic buildup. It is a brilliant survival mechanism. It is. But, um, as I was reading through the source material, there was a biological contradiction that completely stopped me on my track.
14:47Oh, I think I know what you're going to say. The SOX 10 finding. Yes. Wait a second. The study highlights that the gene SOX 10 is heavily involved in driving these resilient protective responses in both the mg.c4 microglia and the ass and about C1 astrosytes.
15:03Right. But isn't SOX 10 strictly an oligodendracite marker? All egodendrocytes are the cells that manufacture that myelin insulation we just talked about. Why on earth is an oligotendocyte, master regulator, suddenly calling the shots inside microblia and astrosytes?
15:18What's fascinating here is that this apparent contradiction is exactly what makes biology so beautifully complex and adaptable. It's a phenomenon known as ectopic expression. Topic expression. Okay. Right.
15:28Under normal healthy conditions, your textbook is absolutely right. SOX 10 is the master regulatory director for all agodendracites. It has no business being active in an astrosite or a microglial cell.
15:42So what changes? In response to the extreme relentless stress of Tao pathology, these specific microglia and astrocytes are essentially borrowing a genetic program that is normally reserved for an entirely different cell type.
15:56That is wild. They're literally stealing the blueprints from the allagadendro sites just to survive the Tao storm. Exactly. They are reaching into the locked vault, pulling out a book they never normally read, and using it as a specialized survival manual.
16:10Wow. And the researchers didn't just observe this weird phenomenon in the postmortem brain tissue. They went back to the lab to prove it functionally. This is where their in vitro validation comes in. Right.
16:19They had prove it wasn't a fluke. Exactly. They took human microglia derived from induced pleuropotent stem cells. Then, using a technology called CRISPRA, the A stands for activation, which allows you to artificially force a specific gene to turn on.
16:33They forced these lab grown, healthy microglia to express SOX 10. Okay, so you take these blank slate, lab grown microglia, you hotwire them with CRISPR to force them to read the SOX 10 survival manual, and then you expose them to actual disease pathology.
16:50Yes. In this case, they drop them into a dish with toxic tousinaptisomes, which are essentially disease toxic synaptic endings taken straight from the brands of human PSP patients. If they've successfully turned on a survival program borrowed from an entirely different cell, I would expect those lab grown microglia to suddenly change their behavior.
17:09Do they start acting like that specialized hazmat crew we saw in the human brains? Spot on, the result was absolutely stunning, the hot wired microlia that had SOX 10 artificially activated, drastically amplified their lysosomal and fag acidic programs.
17:22So they started eating the garbage. Aggressively. They ramped up their ability to eat and digest the toxic tau debris. They perfectly mimicked the protective MGC 4 state that was observed in the actual end stage human brain tissue.
17:37That is amazing. It proved, without a doubt, that SOX 10 isn't just incidentally turned on by accident. It is acting as a critical stress responsive regulator that directly amplifies the cell's natural defense mechanisms when exposed to disease.
17:50So, what does this all mean? Let's step back and look at the whole board. We've got microglia transforming into specialized hazmat crews to eat fatty debris in picks disease, and we have astracite supercharging their delivery trucks and loading bays to beat traffic jams in PSP.
18:07And both of them are borrowing a survival manual from all the gadendrosides to pull it off. How does this fundamentally shift our understanding of treating dementia? Well, for years, the dominant paradigm in the neurology field has been to focus on broadly suppressing neuro inflammation.
18:21Right, just calm everything down. The traditional thought process was simple. The brain is inflamed, the glia look overactive and angry. Therefore, we need to design drugs to turn them off. But this study completely shatters that view.
18:34they're actually trying to help. Exactly. It proves that glial activation is not a single uniform inflammatory fire alarm. Instead, underlying genetic risk shapes highly specific, tailored, and protective stress responses, like that lipid clearance in PDD, or the vesicle trafficking in PSP.
18:54We've been looking at it like a single chaotic riot that needs to be suppressed, but it's actually a highly coordinated emergency response system where different 1st responders are doing very different, very necessary jobs to keep the city from burning down.
19:08If we connect this to the bigger picture, This provides an entirely new therapeutic roadmap. Instead of trying to develop blunt force drugs that broadly turn off the immune system, which, ironically, might actually be stopping these cells from clearing the toxic debris.
19:21Oh, wow, making it worse. Right. Future drugs could specifically target these resilient regulatory networks. Imagine a targeted treatment that specifically boosts the MEF2C network in Microglia to enhance lipid clearance in a pick's patient.
19:36Or a drug that targets the SOX 10 pathway to upregulate that natural garbage disposal system in an Alzheimer's patient. Exactly. We can medically assist and even amplify the brain's own bespoke defense mechanisms.
19:49That is a total 180 degree turn from how we usually think about neuroinflammation. It is incredibly hopeful. But, you know, to keep us scientifically grounded, I have to ask about the boundaries of the study, we were looking at human postmortem tissue, which is dead, and we were looking at cells in a dish, which are isolated.
20:07What are the limitations here? What don't we know yet? This raises an important question about scientific rigor, and you hit the nail on the head regarding postmortem tissue. Because this epigenomic data comes from end stage human brains, it acts as a high resolution photograph taken at the very end of a devastating disease.
20:24So it's a snapshot. Yes, it is very difficult to see the full temporal timeline. We don't know exactly when these chromatin changes occur over the decades of disease progression. When does the hazmat crew 1st arrive and when do they finally get overwhelmed?
20:39Right. We just see the aftermath. Furthermore, while the in Vitro Crispora and NPR models are incredibly powerful for proving mechanisms, a microglial cell isolated in a plastic dish is not a whole brain.
20:52Future research will absolutely need spatial, transcriptomics, and proteomic readouts. To see them in their natural habitat. Exactly. We need to confirm exactly how these proteins are interacting with each other in a living, intact brain structure, surrounded by all its complex cellular neighborhoods.
21:09So the map we have today is incredibly detailed, and it shows us all the secret passages, but it's still a 2D map. The next generation of research needs to be the 3D real-time movie of it happening. That's a perfect way to phrase it.
21:21But to summarize where this groundbreaking work leaves us right now, neurodegenerative genetic risk is not static. It heavily influences how glial cells dynamically rewire their epigenomes in response to severe stress, by identifying specific, resilient glial states, like the lipid clearing microglia and PVD and the vesicle trafficking astracides and PSP, we now possess high resolution maps of the non-coding regulatory circuits that protect the brain from collapse.
21:48We started out talking about the support staff of the brain, and it turns out the way they read the genetic instruction manual, and sometimes skill pages from other manuals, during a crisis, might be the key to everything.
21:59So I'll leave you with this. What does this mean for the future of personalized neurology? If your unique genetic background dictates how your brain supports cells respond to stress, could the dementia treatments of tomorrow be tailored not just to the disease, but to the specific epigenomic wiring of your own glia?
22:16It's a fascinating thought. This episode was based on an open access article under the CCBY 4.0 license. You can find a direct link to the paper and the license in our episode description. If you enjoyed this, follow or subscribe in your podcast app and leave a 5 star rating.
22:32If you'd like to support our work, use the donation link in the description. Now stay with us for an original track created, especially for this episode, and inspired by the article you've just heard about.
22:42Thanks for listening, and join us next time as we explore more science based by base.
